by John Conrad | Aug 5, 2024 | NewsBrief
COUR Pharmaceuticals, a clinical-stage biotech company focused on developing treatments for autoimmune and inflammatory diseases, has announced a significant leadership transition. Founder John J. Puisis will step down as President and Chief Executive Officer, handing...
by John Conrad | Aug 2, 2024 | iBIO News
NewsBrief Weekly News Quiz: August 2nd Friday Biotech Buzz: Weekly Knowledge Challenge 🧬🔬 Calling all life science aficionados! It’s time for our weekly iBIO NewsBrief Quiz. How well have you kept up with the latest breakthroughs? Let’s put your...
by John Conrad | Aug 2, 2024 | NewsBrief
On August 1, 2024, AbbVie completed its acquisition of Cerevel Therapeutics, marking a significant milestone in the quest to improve treatments for millions of people living with neurological and psychiatric conditions. This union brings together two companies...
by John Conrad | Aug 1, 2024 | NewsBrief
In a significant move to boost scientific innovation and commercialization, Portal Innovations is partnering with the University of Chicago’s Polsky Center for Entrepreneurship and Innovation to create a new science startup incubator. The collaboration will see...
by John Conrad | Aug 1, 2024 | NewsBrief
A team of researchers at the University of Illinois Urbana-Champaign (UIUC) has made a significant breakthrough in brain imaging technology that could revolutionize the diagnosis and treatment of Alzheimer’s disease. The study, published on July 31, 2024, in ACS...
